For this research work, the drug delivery nanoplatform HPDA-ABS/PEG-BEZ235/Ce6 (H-APBC) in combination with phototherapy has been constructed to increase intracellular acidity, inhibit PI3K/mTOR signal and attenuate HIF-1α-dependent tumor hypoxia adaptation. Here, MTOR is linked to neoplasm.